The Challenges and the Promise of Molecular Targeted Therapy in Malignant Gliomas
Malignant gliomas are the most common malignant primary brain tumors and one of the most challenging forms of cancers to treat. Despite advances in conventional treatment, the outcome for patients remains almost universally fatal. This poor prognosis is due to therapeutic resistance and tumor recur...
Main Authors: | Hongxiang Wang, Tao Xu, Ying Jiang, Hanchong Xu, Yong Yan, Da Fu, Juxiang Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2015-03-01
|
Series: | Neoplasia: An International Journal for Oncology Research |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1476558615000202 |
Similar Items
-
Gene Fusion in Malignant Glioma: An Emerging Target for Next-Generation Personalized Treatment
by: Tao Xu, et al.
Published: (2018-06-01) -
Combining molecular targeted agents with radiation therapy for malignant gliomas
by: Minniti G, et al.
Published: (2013-08-01) -
Oncogene addiction in gliomas: Implications for molecular targeted therapy
by: Jiang Tao, et al.
Published: (2011-05-01) -
Targeted therapy in the treatment of malignant gliomas
by: Rimas V Lukas, et al.
Published: (2009-05-01) -
Microglia and Macrophages in Malignant Gliomas: Recent Discoveries and Implications for Promising Therapies
by: Anna Carolina Carvalho da Fonseca, et al.
Published: (2013-01-01)